Clinical trial
Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
NCT00459862
Study timeline
Study start (unknown)2007-03-01Date precision: month
Registry last updated2015-02-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Malignant Mesotheliomaunresolved
Localized Malignant Mesotheliomaunresolved
Recurrent Malignant Mesotheliomaunresolved
Interventions
pazopanib hydrochlorideDRUG · verified · RxNorm: pazopanib hydrochloride
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00459862 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.